Ambu A/S Stock
Stocks
AMBU B
DK0060946788
Medical Equipment, Supplies & Distribution
OTC Markets Traded|
Market Closed -
Nasdaq Copenhagen
11:20:00 2026-09-11 EDT
|
5-day change | 1st Jan Change | ||
| 65.40 DKK | -1.13% |
|
-3.89% | -25.68% |
| 09-09 | JP Morgan cuts Coloplast, puts Ambu and Elekta on negative watch - BN | FW |
| 08-27 | SEB cuts price target for Ambu to 130 Danish kroner (152), reiterates buy | FW |
| Market Cap | 17.26B 2.68B 2.31B 2.19B 1.98B 3.72B 256B 3.74B 25.96B 9.98B 130B 10.06B 9.84B 411B | P/E 2026 * |
27.3x | P/E 2027 * | 21.4x |
|---|---|---|---|---|---|
| Enterprise Value | 16.62B 2.58B 2.22B 2.11B 1.91B 3.58B 247B 3.6B 25B 9.61B 125B 9.69B 9.48B 396B | EV / Sales 2026 * |
2.58x | EV / Sales 2027 * | 2.3x |
| Free-Float |
86.18% | Yield 2026 * |
0.72% | Yield 2027 * | 0.88% |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq Copenhagen
| AMBU B | Delayed | |
CBOE
| AMBUBc | Real-time | |
OTC Markets
| AMBFF | Delayed | |
London S.E.
| 0MJF | Delayed | |
Tradegate
| 547A | Real-time | |
CBOE
| 0MJF | Real-time | |
Deutsche Boerse AG
| 547A | Delayed | |
Börse Stuttgart
| 547A | Delayed | |
Boerse Muenchen
| 547A | Real-time | |
Wiener Boerse
| AMBU | End-of-day quote |
Last Transcript : Ambu A/S
| 1 day | -1.13% | ||
| 1 week | -3.89% | ||
| Current month | -8.08% | ||
| 1 month | -11.62% | ||
| 3 months | +3.40% | ||
| 6 months | -10.47% | ||
| Current year | -25.68% |
| 1 week | 65.15 | 68.3 | |
| 1 month | 64.05 | 79.3 | |
| Current year | 56.25 | 92.15 | |
| 1 year | 56.25 | 111.8 | |
| 3 years | 56.25 | 154.6 | |
| 5 years | 56.25 | 225.6 | |
| 10 years | 52 | 358.7 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 53 | 2022-05-19 | |
| Director of Finance/CFO | 42 | 2023-12-31 | |
| Chief Operating Officer | 53 | 2024-06-09 |
| Director | Title | Age | Since |
|---|---|---|---|
Jørgen Jensen
CHM | Chairman | 58 | 2020-12-08 |
Susanne Larsson
BRD | Director/Board Member | 58 | 2021-12-13 |
| Director/Board Member | 63 | 2021-12-13 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 12/4/25 | Buy | Chief Financial Officer | 10,500 | 0.0045% | ||
| 11/7/25 | Buy | Chief Executive Officer | 20,000 | 0.0583% | ||
| 11/7/25 | Buy | Chief Executive Officer | 20,000 | 0.0583% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.13% | -3.89% | -32.02% | -16.48% | 2.68B | ||
| -1.36% | -5.89% | -23.14% | -0.49% | 176B | ||
| -0.72% | -3.41% | -3.49% | +11.74% | 116B | ||
| +0.19% | -2.83% | +6.20% | +80.93% | 61.36B | ||
| -1.92% | -6.01% | +8.80% | +41.11% | 49.42B | ||
| +0.81% | -3.73% | -6.67% | -33.43% | 48.44B | ||
| -1.75% | -5.54% | +9.25% | -22.61% | 31.33B | ||
| +0.43% | -11.10% | - | - | 28.56B | ||
| +0.58% | +1.84% | +31.28% | -12.82% | 24.37B | ||
| +0.49% | -7.65% | -12.44% | +4.86% | 21.57B | ||
| Average | -0.44% | -4.96% | -2.47% | +5.87% | 56.05B | |
| Weighted average by Cap. | -0.69% | -4.89% | -6.20% | +10.71% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 6.44B 1B 861M 816M 739M 1.39B 95.51B 1.39B 9.69B 3.72B 48.59B 3.75B 3.67B 154B | 7.16B 1.11B 958M 907M 822M 1.54B 106B 1.55B 10.77B 4.14B 54.03B 4.17B 4.08B 171B |
| Net income | 635M 98.6M 84.95M 80.44M 72.91M 137M 9.42B 137M 955M 367M 4.79B 370M 362M 15.14B | 803M 125M 107M 102M 92.19M 173M 11.91B 174M 1.21B 465M 6.06B 468M 458M 19.15B |
| Net Debt | -635M -98.57M -84.93M -80.41M -72.89M -137M -9.42B -137M -955M -367M -4.79B -370M -362M -15.14B | -776M -120M -104M -98.29M -89.09M -167M -11.51B -168M -1.17B -449M -5.86B -452M -443M -18.5B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-11 | DKK 65.40 | -1.13% | 505,192 |
| 26-09-10 | DKK 66.15 | +0.38% | 469,099 |
| 26-09-09 | DKK 65.90 | -1.35% | 813,823 |
| 26-09-08 | DKK 66.80 | -1.18% | 743,424 |
| 26-09-07 | DKK 67.60 | -0.66% | 401,046 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- AMBU B Stock
Select your edition
All financial news and data tailored to specific country editions

















